The companies said that their vaccine was safe and effective in that age group, and that they would submit a formal request in the coming weeks to U.S. regulators to allow a pediatric dose.

from NYT > Health https://ift.tt/39K2A7B

0 comments:

Post a Comment

Popular Posts